The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Post close NOT delayed report trades
16:36:29 Buy 20,000,000 @ 0.0945
16:36:53 Buy 25,000,000 @ 0.0875
Total Traded 396,386,385
DDx
Well done team BBSN
"Net cash of £6.8m, an increase of £2.5m from 30 June 2023 (H1 23: £4.3m) and an increase of £0.6m year-on-year (FY22: £6.2m), with one acquisition made in the period. Revolving credit facility of £3.0m remains undrawn, providing further liquidity if required."
"Market expectations for FY24 are to deliver net revenue of £21.0m and Adj. EBITDA of £4.2m. Net cash is expected to be in excess of £9m at year end."
Full year cumulative volumes increased 8%
Full year cumulative revenues increased 17% to £1.55m (FY2023 £1.32m)
Full year cumulative gross profit increased 11% to £759k (FY2023 £683k)
Bobby; many thanks for your two very useful and informative posts; a simple question, what share price would represent fair value for distil...
Best Regards DD
Https://www.linkedin.com/feed/update/urn:li:activity:7176647114058268673/
A strong appointment by LST
https://www.linkedin.com/in/grahamcooley/
After the second closing CPX will have 2.9 billion shares currently trading at 0.1p or an MCap of £2.9m with £2m in the bank. So, an enterprise value of £900k.
From the Total Voting Rights RNS on 28th March "Application will be made for the Second Placing Shares, Subscription Shares and the Retail Offer Shares to be admitted to trading on AIM ("Second Admission") and the date on which Second Admission is expected to become effective is on or around 25 April 2024. Following Second Admission, the Company's issued ordinary share capital will consist of 2,908,226,437 Ordinary Shares with one voting right each."
His "visit my website" goes straight to the LST website!
Take a look at Light Science; LST.L appointment of Dr. C as Chairman!
Great RNS; "Valued at £130,000 and anticipated for delivery to the customer in April, this venture holds significant potential for follow on revenue in this new segment." and "UKC has secured orders since the start of the current financial year totalling c.£1.4 million in the pest control sector." and "Currently, the forward order book for the CEM division stands at c.£4.1m, putting it on track....."
I see that Redleg Rum is now on the shelves in Sainsburys, Tesco and Morrison's!
https://www.google.com/search?sca_esv=591690802&rlz=1C1GCEU_en-GBGB1062GB1062&q=redleg+rum&tbm=isch&source=lnms&sa=X&sqi=2&ved=2ahUKEwith9D3hZeDAxXXgv0HHR5zCx4Q0pQJegQICxAB&biw=2400&bih=1148&dpr=1.25
Those are sells not buys; final position 0% if I'm reading correctly?
"EAAS closed today at 5.75p reflecting a Market Cap of £20m.
If the Energy Management division represents 30% of the value of eEnergy and they sell it for £30m then the value of eEnergy is ~£90m (£30m being cash on the balance sheet).
£90m Market Cap is a Share Price of 4.5x 5.75p = ~26p
DYOR"
Its great to see this endorsement
Quantum; already now trading at 3p but its very difficult to buy online; getting a quote for even a small amount of shares is impossible!
This comes from the LST thread on ADVFN; worth reading me thinks....
"Today’s announcement is a very significant development in my view, which is not only earnings enhancing but also cash enhancing. It looks to me like a few details have been missed by the market which are worth restating here.
The deal is cash enhancing:
The initial cash outlay is GBP75,000, with Tomtech's balance sheet included cash c.GBP284,000.
The deal is immediately earnings enhancing in the current reporting period:
Tomtech reported profits before tax of c.GBP79,000 on sales of c.GBP680,000 of which GBP49,000 was recurring revenue.
Loyal CEA customer base across the UK and Ireland built up over 35 years
I also noted during trading today that the MM’s ran short of stock. Indeed, there were periods of strong buying followed by a bid lockdown on most online channels often lasting over 30mins. The market just kept running out of stock. One of those rare occasions when supply of stock was extreme enough to suppress progress. It will be interesting to see what happens tomorrow.
DYOR
I just tried again to buy but cant get a price; the MMs must be out of stock!
Tighter spread than usual; a good sign...
Much needed liquidity
Analystium 30 Aug '23 - 18:15
The TR1 on 25th Aug from Amati AIM VCT plc explains a lot.
The transition from 4p to 2.5p in May was clearly the funding round; my expectation was for VLS to trade back to 4p relatively quickly. The transition from 2.5p to 1.5p is now also clear and is a classic overhang with Amati AIM VCT moving from 3.91% to 2.89%; with 48m shares left last week.
So; do they need to sell it all? I assume that an AIM VCT cant hold US dual listed shares and this is the reason for them exiting; but I may be wrong; perhaps someone here could clarify?
We wont see another TR1 because they have dipped below 3% but at 1.5p per share with about 40m left that's £600k of sales to clear the overhang.
I'm with "The Imperialist", this is now a special market situation which may unwind quickly...
DYOR